Showing results (611-620 of 701) with videos related to

Sort By:
Pageof 71
Journal of the American Society of Nephrology : JASN|March 29, 2026
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and FinerenoneRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.
Plos One|October 27, 2010
Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathyAlaa Alkhalaf, Petra Zürbig, Stephan J L Bakker, et al.
Diabetologia|April 21, 2022
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trialSimke W Waijer, Priya Vart, David Z I Cherney, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 30, 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney FoundationKatherine R Tuttle, Frank C Brosius, Matthew A Cavender, et al.
Nature Medicine|June 24, 2024
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trialJohannes F E Mann, Peter Rossing, George Bakris, et al.
Diabetes|October 27, 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney FoundationKatherine R Tuttle, Frank C Brosius, Matthew A Cavender, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2017
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trialJohn R Petrie, Nishi Chaturvedi, Ian Ford, et al.
Circulation|November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular DiseaseJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
BMC Nephrology|September 10, 2016
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysisGemma Currie, Alison H M Taylor, Toshiro Fujita, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2025
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populationsHiddo J L Heerspink, Rajiv Agarwal, Antonio J Amor, et al.
Pageof 71